Elaxim 40

Elaxim 40 is a prescription injectable thrombolytic medicine containing Tenecteplase 40 mg, shown as a Gennova Biopharmaceuticals product. It is used in emergency hospital settings for acute myocardial infarction, commonly known as heart attack, to help dissolve harmful blood clots and restore blood flow. Tiny vial, full “call the cardiology team, not your cousin on WhatsApp” seriousness.  Gennova describes Elaxim as biosimilar tenecteplase, a third-generation thrombolytic modified from natural tissue plasminogen activator and indicated for reducing mortality associated with acute myocardial infarction.

Composition:

Tenecteplase / TNK-tPA – 40 mg
Recombinant Tissue Plasminogen Activator for Injection

Key Information:

Brand Name: Elaxim 40
Strength: 40 mg
Active Ingredient: Tenecteplase
Dosage Form: Injection / Lyophilized powder for injection
Medicine Type: Thrombolytic agent / Clot-dissolving medicine
Manufacturer/Brand Shown: Gennova Biopharmaceuticals Ltd.
Common Use: Emergency treatment of acute myocardial infarction / heart attack
Administration: Intravenous use by trained healthcare professionals
Category: Prescription emergency medicine
Pack Size: 1 vial, as visible in the image

How It Works:

Elaxim 40 works by helping dissolve blood clots inside blood vessels. Tenecteplase is a tissue plasminogen activator that helps convert plasminogen into plasmin, which breaks down fibrin, a major part of blood clots. This can help restore blood flow in blocked heart vessels during a heart attack.

Potential Indications:

• Acute myocardial infarction
• ST-elevation myocardial infarction, also called STEMI
• Emergency clot-dissolving therapy in heart attack
• Other doctor-directed thrombolytic use in hospital settings

Dosage & Storage:

Use only as directed by a qualified healthcare professional.
This injection should be prepared and administered only by trained medical staff.
Do not self-administer.
Gennova notes that Elaxim is available in 30 mg, 40 mg, and 52.5 mg vial presentations for single intravenous bolus administration.
Store strictly as per product label and hospital pharmacy instructions, because this is not the kind of thing that belongs beside cough syrup and expired snacks.
Keep out of reach of children.

Important Safety Information:

Tenecteplase should be used only in emergency medical settings with proper monitoring. It may increase the risk of serious bleeding, including internal bleeding. It should be used carefully in patients with recent surgery, stroke history, uncontrolled high blood pressure, active bleeding, head injury, bleeding disorders, or those taking blood thinners.

Possible side effects may include:

• Bleeding
• Injection-site bleeding
• Nosebleed
• Blood in urine or stool
• Low blood pressure
• Allergic reaction
• Irregular heartbeat after restoration of blood flow
• Serious internal bleeding in rare cases
• Stroke or brain bleeding in high-risk patients

Official tenecteplase labeling lists bleeding and hypersensitivity as important adverse reactions, and thrombolytic therapy requires careful patient selection and monitoring.

Label Verification:

Please double-check the physical product label before listing or use, including product name, strength, active ingredient, manufacturer details, batch number, expiry date, storage instructions, reconstitution instructions, dosage directions, and route of administration.

General Information Disclaimer:

The information provided here is for general educational and product-identification purposes only. It should not be considered medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before starting, stopping, or changing any medication regimen.